Despite evidence for widespread transcriptome changes in tumours after drug treatment, detailed and systematic knowledge of the direction and amplitude of transcriptional changes of individual HDAC and SIRT genes in response to various agents remains limited. The gene discussed is HDAC9; the disease is neoplasm.